Literature DB >> 22971746

Notes from the field: Highly pathogenic avian influenza A (H7N3) virus infection in two poultry workers--Jalisco, Mexico, July 2012.

.   

Abstract

During June-August 2012, Mexico's National Service for Health, Safety, and Food Quality reported outbreaks of highly pathogenic avian influenza (HPAI) A (H7N3) virus in poultry on farms throughout the state of Jalisco. This report describes two cases of conjunctivitis without fever or respiratory symptoms caused by HPAI A (H7N3) virus infection in humans associated with exposure to infected poultry.

Entities:  

Mesh：

Year:  2012        PMID： 22971746

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


  42 in total

1.  A novel eight amino acid insertion contributes to the hemagglutinin cleavability and the virulence of a highly pathogenic avian influenza A (H7N3) virus in mice.

Authors:  Xiangjie Sun; Jessica A Belser; Terrence M Tumpey
Journal:  Virology       Date:  2015-11-26       Impact factor: 3.616

2.  Unique Structural Features of Influenza Virus H15 Hemagglutinin.

Authors:  Netanel Tzarum; Ryan McBride; Corwin M Nycholat; Wenjie Peng; James C Paulson; Ian A Wilson
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

3.  Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.

Authors:  Florian Krammer; Rong Hai; Mark Yondola; Gene S Tan; Victor H Leyva-Grado; Alex B Ryder; Matthew S Miller; John K Rose; Peter Palese; Adolfo García-Sastre; Randy A Albrecht
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

4.  Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.

Authors:  Hyeok-Il Kwon; Young-Il Kim; Su-Jin Park; Min-Suk Song; Eun-Ha Kim; Se Mi Kim; Young-Jae Si; In-Won Lee; Byung-Min Song; Youn-Jeong Lee; Seok Joong Yun; Wun-Jae Kim; Young Ki Choi
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

5.  Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine.

Authors:  Changgui Li; Kangwei Xu; Anwar Hashem; Ming Shao; Shuzhen Liu; Yong Zou; Qiang Gao; Yongchao Zhang; Liyong Yuan; Miao Xu; Xuguang Li; Junzhi Wang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

Authors:  I Margine; F Krammer; R Hai; N S Heaton; G S Tan; S A Andrews; J A Runstadler; P C Wilson; R A Albrecht; A García-Sastre; P Palese
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

7.  Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis.

Authors:  Jessica A Belser; C Todd Davis; Amanda Balish; Lindsay E Edwards; Hui Zeng; Taronna R Maines; Kortney M Gustin; Irma López Martínez; Rodrigo Fasce; Nancy J Cox; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

8.  H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice.

Authors:  Juliet Morrison; Laurence Josset; Nicolas Tchitchek; Jean Chang; Jessica A Belser; David E Swayne; Mary J Pantin-Jackwood; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

9.  H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice.

Authors:  Irina Margine; Rong Hai; Randy A Albrecht; Gerlinde Obermoser; A Carson Harrod; Jacques Banchereau; Karolina Palucka; Adolfo García-Sastre; Peter Palese; John J Treanor; Florian Krammer
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

10.  Avian influenza A viruses: from zoonosis to pandemic.

Authors:  Mathilde Richard; Miranda de Graaf; Sander Herfst
Journal:  Future Virol       Date:  2014-05-01       Impact factor: 1.831
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.